Patent · US Active

Clusterin derived peptide

US8575107B2 · kind B2 · utility

0Cited by
10References
6Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJan 22, 2009
Grant dateNov 5, 2013
Priority date
Expiry dateJan 24, 2030

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Clusterin-derived peptides or homologues or derivatives thereof, pharmaceutical compositions including the same, methods of manufacturing the peptides, homologues, derivatives thereof and compositions including the same, and methods of treating conditions including administering the peptides, homologues, derivatives thereof and compositions including the same, are provided. Also provided are nucleotide sequences encoding the peptides, homologues, derivatives thereof and compositions including the same, antibodies directed to epitopes thereof and fusion proteins including the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.